P.A.W. Capital Corp Eiger Bio Pharmaceuticals, Inc. Transaction History

P.A.W. Capital Corp

$44.3 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.02 - $7.48 $295,800 - $2.17 Million	-290,000 Reduced 53.7%	250,000 $295,000
Q1 2022 Apr 21, 2022	BUY	$3.84 - $9.74 $153,600 - $389,600	40,000 Added 8.0%	540,000 $4.48 Million
Q4 2021 Feb 10, 2022	BUY	$5.12 - $8.19 $512,000 - $819,000	100,000 Added 25.0%	500,000 $2.6 Million
Q2 2021 Aug 05, 2021	BUY	$7.82 - $9.23 $156,400 - $184,600	20,000 Added 5.26%	400,000 $3.41 Million
Q1 2021 May 10, 2021	SELL	$8.44 - $12.66 $168,800 - $253,200	-20,000 Reduced 5.0%	380,000 $3.36 Million
Q4 2020 Feb 11, 2021	BUY	$7.98 - $12.29 $319,200 - $491,599	40,000 Added 11.11%	400,000 $4.92 Million
Q3 2020 Nov 09, 2020	BUY	$7.96 - $12.42 $477,600 - $745,200	60,000 Added 20.0%	360,000 $2.93 Million
Q2 2020 Jul 27, 2020	SELL	$5.4 - $13.37 $324,000 - $802,200	-60,000 Reduced 16.67%	300,000 $2.88 Million
Q1 2020 May 08, 2020	BUY	$4.91 - $14.7 $1.06 Million - $3.18 Million	216,000 Added 150.0%	360,000 $2.45 Million
Q4 2019 Jan 28, 2020	SELL	$9.77 - $15.66 $547,120 - $876,960	-56,000 Reduced 28.0%	144,000 $2.15 Million
Q2 2019 Jul 31, 2019	BUY	$9.54 - $14.96 $95,399 - $149,600	10,000 Added 5.26%	200,000 $2.12 Million
Q1 2019 Apr 17, 2019	SELL	$10.31 - $14.38 $309,300 - $431,400	-30,000 Reduced 13.64%	190,000 $2.66 Million
Q4 2018 Feb 06, 2019	BUY	$8.63 - $12.4 $1.6 Million - $2.29 Million	185,000 Added 528.57%	220,000 $2.24 Million
Q3 2018 Oct 24, 2018	SELL	$9.6 - $12.9 $528,000 - $709,500	-55,000 Reduced 61.11%	35,000 $420,000
Q2 2018 Jul 25, 2018	SELL	$8.3 - $16.8 $373,500 - $756,000	-45,000 Reduced 33.33%	90,000 $1.1 Million
Q1 2018 Apr 26, 2018	BUY	$8.1 - $16.0 $283,500 - $560,000	35,000 Added 35.0%	135,000 $1.33 Million
Q4 2017 Jan 31, 2018	BUY	$10.5 - $14.15 $210,000 - $283,000	20,000 Added 25.0%	100,000 $1.4 Million
Q3 2017 Oct 23, 2017	BUY	$7.7 - $11.55 $616,000 - $924,000	80,000	80,000 $880,000

Others Institutions Holding EIGR

# of Institutions

Shares Held

748K

Call Options Held

Put Options Held

View Full List

About Eiger BioPharmaceuticals, Inc.

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

More about EIGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on P.A.W. Capital Corp with notifications on news.

Account